Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 10
Submit an article Journal homepage
78
Views
3
CrossRef citations to date
0
Altmetric
Original Scientific Papers

The prognostic value of C-reactive protein to albumin ratio in patients undergoing transcatheter aortic valve implantation

Yalcin Avcia Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2334-5007
ORCID Icon,
Ali Riza Demira Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Mustafa Duranb Department of Cardiology, Konya City Hospital, Konya, Turkey
,
Umit Buluta Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Gökhan Demircia Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Begum Uygura Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Omer Tasbulaka Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Arda Can Doğana Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
,
Omer Celika Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
&
Mehmet Erturka Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology, University of Health Sciences, Istanbul, Turkey
 show all
Pages 930-936 | Received 26 Nov 2021, Accepted 26 Aug 2022, Published online: 05 Oct 2022

References

  • Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). The joint task force on the management of valvular heart disease of the european society of cardiology (ESC) and the european association for Cardio-Thoracic surgery (EACTS). G Ital Cardiol (Rome). 2013;14(3):167–214. Italian.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients With valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129(23):e521–e643. Dosage error in article text.
  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
  • Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;64(23):2187–2198.
  • Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–744.
  • Anderson RP. First publications from the society of thoracic surgeons national database. Ann Thorac Surg. 1994;57(1):6–7.
  • Zhou T, Zhan J, Hong S, et al. Ratio of C-reactive protein/albumin is an ınflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep. 2015;5(1):10481.
  • Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321.
  • Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5):S45–S60.
  • Young Lee M, Chilakamarri Yeshwant S, Chava S, et al. Mechanisms of heart block after transcatheter aortic valve replacement - cardiac anatomy, clinical predictors and mechanical factors that contribute to permanent pacemaker implantation. Arrhythm Electrophysiol Rev. 2015;4(2):81–85.
  • Giordana F, D'Ascenzo F, Nijhoff F, et al. Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation. Am J Cardiol. 2014;114(9):1447–1455.
  • Skowasch D, Schrempf S, Preusse CJ, et al. Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins. Heart. 2005;92(4):495–498.
  • Imai K, Okura H, Kume T, et al. C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J. 2008;156(4):713–718.
  • Hioki H, Watanabe Y, Kozuma K, et al. Effect of serum C-reactive protein level on admission to predict mortality after transcatheter aortic valve ımplantation. Am J Cardiol. 2018;122(2):294–301.
  • Zieliński K, Kalińczuk Ł, Chmielak Z, et al. Additive value of high-density lipoprotein cholesterol and C-reactive protein level assessment for prediction of 2-year mortality after transcatheter aortic valve ımplantation. Am J Cardiol. 2020;126:66–72.
  • Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787.
  • Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–255.
  • Yamamoto M, Shimura T, Kano S, et al. Prognostic value of hypoalbuminemia after transcatheter aortic valve ımplantation (from the Japanese Multicenter OCEAN-TAVI registry). Am J Cardiol. 2017;119(5):770–777.
  • Emami S, Rudasill S, Bellamkonda N, et al. Impact of malnutrition on outcomes following transcatheter aortic valve implantation (from a national cohort). Am J Cardiol. 2020;125(7):1096–1101.
  • Fairclough E, Cairns E, Hamilton J, et al. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med. 2009;9(1):30–33.
  • Moon JS, Ahn SS, Park YB, et al. C-Reactive protein to serum albumin ratio is an independent predictor of all-cause mortality in patients with ANCA-associated vasculitis. Yonsei Med J. 2018;59(7):865–871.
  • Park JE, Chung KS, Song JH, et al. The C-reactive protein/albumin ratio as a predictor of mortality in critically ill patients. JCM. 2018;7(10):333.
  • Kinoshita A, Onoda H, Imai N, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803–810.
  • Kahraman S, Dogan AC, Demirci G, et al. The prognostic value of C-reactive protein to albumin ratio in patients with ısolated degenerative aortic valve stenosis undergoing surgical aortic valve replacement. Braz J Cardiovasc Surg. 2020;35(3):299–306.
  • Wang W, Ren D, Wang CS, et al. Prognostic efficacy of high-sensitivity C-reactive protein to albumin ratio in patients with acute coronary syndrome. Biomark Med. 2019;13(10):811–820.
  • Çağdaş M, Rencüzoğullari I, Karakoyun S, et al. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019;70(4):361–368.
  • Rencuzogullari I, Karabağ Y, Çağdaş M, et al. Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2019;38(4):269–277.
  • Süleymanoğlu M, Burak C, Gümüşdağ A, et al. Prognostic value of C-reactive protein to albumin ratio for long-term outcomes of patients with peripheral arterial disease underwent endovascular treatment. Vascular. 2022;30(3):481–489.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.